TMTC3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.622800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.062400E-01
Normal-vs-Stage2
9.762600E-01
Normal-vs-Stage3
4.429000E-01
Normal-vs-Stage4
6.158400E-01
Stage1-vs-Stage2
7.973400E-01
Stage1-vs-Stage3
1.866410E-01
Stage1-vs-Stage4
6.475800E-01
Stage2-vs-Stage3
3.458600E-01
Stage2-vs-Stage4
5.248000E-01
Stage3-vs-Stage4
1.782380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.947400E-01
Normal-vs-AfricanAmerican
5.948200E-01
Normal-vs-Asian
6.721800E-01
Caucasian-vs-AfricanAmerican
3.260200E-01
Caucasian-vs-Asian
4.080800E-01
AfricanAmerican-vs-Asian
1.992570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.890800E-01
Normal-vs-Female
9.069800E-01
Male-vs-Female
7.369600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.723800E-01
Normal-vs-Age(41-60Yrs)
5.580400E-01
Normal-vs-Age(61-80Yrs)
8.754400E-01
Normal-vs-Age(81-100Yrs)
4.266800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.554200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.913600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.127000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.984200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.823700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.769400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.953000E-01
Normal-vs-Daily Drinker
4.408200E-01
Normal-vs-Weekly Drinker
9.779200E-01
Normal-vs-Occasional Drinker
6.411200E-01
Normal-vs-Social Drinker
8.051200E-01
Non Drinker-vs-Daily Drinker
9.521200E-01
Non Drinker-vs-Weekly Drinker
2.187200E-01
Non Drinker-vs-Occasional Drinker
5.335900E-02
Non Drinker-vs-Social Drinker
1.679170E-01
Daily Drinker-vs-Weekly Drinker
1.920040E-01
Daily Drinker-vs-Occasional Drinker
5.033600E-02
Daily Drinker-vs-Social Drinker
1.597020E-01
Weekly Drinker-vs-Occasional Drinker
2.982200E-01
Weekly Drinker-vs-Social Drinker
5.991600E-01
Occasional Drinker-vs-Social Drinker
6.885400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.444400E-01
Normal-vs-Grade 2
2.998400E-01
Normal-vs-Grade 3
3.834000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.214000E-01
Grade 1-vs-Grade 3
5.842400E-01
Grade 1-vs-Grade 4
4.444400E-01
Grade 2-vs-Grade 3
9.612400E-01
Grade 2-vs-Grade 4
2.998400E-01
Grade 3-vs-Grade 4
3.834000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.911400E-01
Normal-vs-NonDiabetic
9.805600E-01
Diabetic-vs-NonDiabetic
4.262200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.345600E-01
Normal-vs-NoPancreatitis
9.917600E-01
Pancreatitis-vs-NoPancreatitis
3.359800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.654200E-01
Normal-vs-N1
9.369800E-01
N0-vs-N1
6.684200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.355200E-01
Normal-vs-TP53-NonMutant
9.875000E-01
TP53-Mutant-vs-TP53-NonMutant
4.113000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
